Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: avelox / codeine / erythromycin / glucophage / glipizide / penicillins / sulfa (sulfonamides) / tetracycline / shellfish / aspartame attending: chief complaint: sob and angina major surgical or invasive procedure: cabg x3/mv repair (lima to lad, svg to om1, svg to om2, 28 mm ce annuloplasty band) history of present illness: 67 yo female presented to osh with chest pressure and sob and ruled in for nstemi. cath there revealed 90% lad lesions, cx 90%, om 50%, rca 40% with ef 30% significant mr also noted. pt. transferred for surgery at . past medical history: nstemi htn elev. lipids chf diastolic ( ef 50%) niddm retinopathy remote asthma psh: appy, cholecystectomy, cataract , fxs ankle and arm social history: no etoh abuse no current tobacco use family history: sister with premature cad/cabg father with fatal mi at 59 physical exam: 95% on 2l nc 61.5 " 79.9 kg t 100.3, 122/64 st 110 rr 20 nad, and oriented appropriately ncat, perrl, eomi,anicteric neck supple with jvp to jaw rrr s1 s2 no m/r/g bibasilar rales soft, nt, nd,no abd. bruits , no hsm extrems no c/c/e skin unremarkable 2+ bil. fem/dp/pts , no bruits pertinent results: 07:10am blood wbc-18.0* rbc-3.75* hgb-11.1* hct-33.3* mcv-89 mch-29.7 mchc-33.4 rdw-14.5 plt ct-547* 03:44am blood wbc-20.9* rbc-3.87* hgb-11.4* hct-33.4* mcv-86 mch-29.4 mchc-34.0 rdw-14.4 plt ct-436 04:16am blood wbc-18.7* rbc-3.77* hgb-11.4* hct-33.2* mcv-88 mch-30.3 mchc-34.4 rdw-14.5 plt ct-368 07:10am blood plt ct-547* 09:16am blood pt-19.8* inr(pt)-1.8* 04:16am blood pt-17.4* ptt-26.3 inr(pt)-1.6* 02:43am blood pt-17.4* inr(pt)-1.6* 02:20am blood pt-17.3* ptt-27.4 inr(pt)-1.6* 07:10am blood glucose-154* urean-12 creat-0.5 na-137 k-3.9 cl-97 hco3-31 angap-13 echocardiography report , portable tte (complete) done at 1:23:17 pm final referring physician information , r. division of cardiothoracic , status: inpatient dob: age (years): 67 f hgt (in): 62 bp (mm hg): 116/54 wgt (lb): 210 hr (bpm): 92 bsa (m2): 1.95 m2 indication: h/o cardiac surgery. pericardial effusion. prosthetic valve function. icd-9 codes: 423.9, v43.3, 424.0 test information date/time: at 13:23 interpret md: , md test type: portable tte (complete) son: , rdcs doppler: full doppler and color doppler test location: west sicu/ctic/vicu contrast: none tech quality: suboptimal tape #: 2007w046-1:02 machine: vivid echocardiographic measurements results measurements normal range left atrium - long axis dimension: *4.6 cm <= 4.0 cm left ventricle - septal wall thickness: 1.0 cm 0.6 - 1.1 cm left ventricle - inferolateral thickness: 0.9 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: 4.3 cm <= 5.6 cm left ventricle - systolic dimension: 3.1 cm left ventricle - fractional shortening: *0.28 >= 0.29 left ventricle - ejection fraction: 40% to 45% >= 55% aorta - sinus level: 2.4 cm <= 3.6 cm aorta - ascending: 3.0 cm <= 3.4 cm aortic valve - peak velocity: 1.6 m/sec <= 2.0 m/sec mitral valve - e wave: 1.6 m/sec mitral valve - a wave: 0.8 m/sec mitral valve - e/a ratio: 2.00 mitral valve - e wave deceleration time: 244 ms 140-250 ms tr gradient (+ ra = pasp): *35 to 43 mm hg <= 25 mm hg findings this study was compared to the prior study of . left atrium: mild la enlargement. left ventricle: normal lv wall thickness and cavity size. mild-moderate regional lv systolic dysfunction. no resting lvot gradient. right ventricle: rv not well seen. aorta: normal aortic diameter at the sinus level. normal ascending aorta diameter. aortic valve: ?# aortic valve leaflets. no as. no ar. mitral valve: mildly thickened mitral valve leaflets. mitral valve annuloplasty ring. no ms. normal lv inflow pattern for age. tricuspid valve: normal tricuspid valve leaflets. moderate pa systolic hypertension. pulmonic valve/pulmonary artery: normal pulmonic valve leaflets with physiologic pr. pericardium: no pericardial effusion. general comments: suboptimal image quality - poor echo windows. frequent ventricular premature beats. conclusions the left atrium is mildly dilated. left ventricular wall thicknesses and cavity size are normal. there is mild to moderate regional left ventricular systolic dysfunction with severe hypokinesis of the inferior and inferolateral walls and apex. the number of aortic valve leaflets cannot be determined. there is no aortic valve stenosis. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. a mitral valve annuloplasty ring is present. there is moderate pulmonary artery systolic hypertension. there is no pericardial effusion. compared with the prior study (images reviewed) of , there is now a mitral valvuloplasty ring in position. there is no mitral regurgitation. the estimated pulmonary artery systolic pressure is slightly lower. chest (portable ap) 7:29 am chest (portable ap) reason: ? effusion medical condition: 67 year old woman with s/p cabg mv repair reason for this examination: ? effusion history: cabg and mvr repair. findings: in comparison with study of , the endotracheal tube and nasogastric tube have been removed. the swan-ganz catheter tip now lies within the proximal right pulmonary artery. left chest tube remains in place. some atelectatic changes are again seen at the bases. chest (portable ap) 4:31 pm chest (portable ap); -77 by different physician reason: s/p ct removal ? ptx medical condition: 67 year old woman with s/p cabg reason for this examination: s/p ct removal ? ptx portable upright chest, comparison: previous study of earlier the same day. indication: chest tube removal. following removal of left-sided chest tube, no pneumothorax is identified. mediastinal drain has also been removed. swan-ganz catheter remains in place with tip terminating in proximal left pulmonary artery. vascular engorgement and perihilar haziness are minimally improved. bibasilar atelectasis is slightly improved and right pleural effusion appears slightly smaller. brief hospital course: admitted from emmc, and pre-op workup completed over the weekend. underwent cabg x3/mv repair with dr. on . transferred to the cvicu in stable condition on levophed, milrinone, epinephrine, and insulin drips. extubated on pod #1, and went into a fib overnight. converted with amiodarone. given 48 hours of peiop vancomycin as she was in the hospital preoperatively. flagyl started for c. diff. chest tubes and pacing wires removed without incident. vanco po also started. drips also weaned over the next few days. beta blockade titrated and gentle diuresis continued. coumadin and amiodarone started for continued afib. remained in the cvicu over the weekend as private room not avail. on the floor given c. diff. cleared for discharge to rehab on pod #8 target inr 2.0-2.5 for a fib. medications on admission: asa 325 mg daily zestril 2.5 mg lopressor 25 mg q 6h protonix 40 mg daily ss insulin lipitor 80 mg qhs duoneb prn q 4h diazepam 2-5 mg prn ntg paste 1" dermal q6h heparin drip discharge medications: 1. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 4. oxycodone-acetaminophen 5-325 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed for pain. 5. ipratropium-albuterol 18-103 mcg/actuation aerosol sig: two (2) puff inhalation q6h (every 6 hours). 6. zestril 2.5 mg tablet sig: one (1) tablet po once a day. 7. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 8. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). 9. amiodarone 200 mg tablet sig: two (2) tablet po once a day for 1 weeks: 400 mg daily x 1 week, then 200 mg daily. 10. furosemide 20 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 2 weeks. 11. potassium chloride 20 meq packet sig: one (1) packet po q12h (every 12 hours) for 2 weeks. 12. metronidazole 500 mg tablet sig: one (1) tablet po tid (3 times a day) for 8 days. 13. warfarin 1 mg tablet sig: two (2) tablet po daily (daily): check inr and prn, and dose accordingly. 14. vancomycin 250 mg capsule sig: one (1) capsule po q6h (every 6 hours) for 8 days. discharge disposition: extended care facility: tba discharge diagnosis: nstemi cad/mr s/p cab x3/mv repair postop a fib elev. lipids htn chf niddm retinopathy asthma discharge condition: stable discharge instructions: no lotions, creams or powders on any incision shower daily and pat incisions dry no driving for one month no lifting greater than 10 pounds for 10 weeks call for fever greater than 100, redness or drainage followup instructions: see dr. in weeks see dr. in weeks see dr. in 4 weeks procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries annuloplasty transfusion of packed cells transfusion of other serum transfusion of platelets continuous intra-arterial blood gas monitoring diagnoses: subendocardial infarction, initial episode of care anemia, unspecified coronary atherosclerosis of native coronary artery mitral valve disorders congestive heart failure, unspecified unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation asthma, unspecified type, unspecified other and unspecified hyperlipidemia intestinal infection due to clostridium difficile family history of ischemic heart disease acute diastolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy family history of diabetes mellitus 

Answer: The patient is high likely exposed to